In murine models, GLP-1 decreases ischaemia-induced myocardial damage [41], and in patients with heart failure, exogenous GLP-1 has been associated with improvements in left ventricular ejection fraction, myocardial oxygen uptake and 6-min walk distance [42]. The gene discussed is GCG; the disease is heart failure.